NCT03938610 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Fournier JP, Demeester A, Charlin B
Script concordance tests: guidelines for construction. BMC Med Inform Decis Mak. 2008 May 6;8:18. doi: 10.1186/1472-6947-8-18.
Gagnon R, Charlin B, Coletti M, Sauve E, van der Vleuten C
Assessment in the context of uncertainty: how many members are needed on the panel of reference of a script concordance test? Med Educ. 2005 Mar;39(3):284-91. doi: 10.1111/j.1365-2929.2005.02092.x.
O'Neill TR, Li Z, Peabody MR, Lybarger M, Royal K, Puffer JC
The Predictive Validity of the ABFM's In-Training Examination. Fam Med. 2015 May;47(5):349-56.

Do Script Concordance Tests Correlate With Family Medicine Standardized Tests and Failing Rotation Grades?

Clinical trial NCT03938610 - References